Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis J O'Kane

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2003
Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladderJalaluddin Bhuiyan, Javed Akhter, Dennis J O'Kane
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2007
The impact of CYP allelic variation on antidepressant metabolism: a reviewJohn L Black, Dennis J O'Kane, David A Mrazek
Pharmacogenomics|January 9, 2003
Pharmacogenomics and reducing the frequency of adverse drug eventsDennis J O'Kane, Richard M Weinshilboum, Thomas P Moyer
Clinical Chemistry|January 17, 2004
Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytomaSusan A Lagerstedt, Dennis J O'Kane, Ravinder J Singh
Clinical Biochemistry|July 7, 2009
Use of cyst fluid CEA, CA19-9, and amylase for evaluation of pancreatic lesionsChristine L H Snozek, Ranjan C Mascarenhas, Dennis J O'Kane
The Journal of Molecular Diagnostics : JMD|August 1, 2009
Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathologyChristine L H Snozek, Dennis J O'Kane, Alicia Algeciras-Schimnich
Clinics in Laboratory Medicine|December 9, 2008
Pharmacogenomics of tamoxifen and irinotecan therapiesAlicia Algeciras-Schimnich, Dennis J O'Kane, Christine L H Snozek
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2011
Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype predictionJohn Logan Black, Denise L Walker, Dennis J O'Kane, et al.
Mayo Clinic Proceedings|September 7, 2007
Cytochrome P450 2D6 genotype variation and venlafaxine dosageDonald E McAlpine, Dennis J O'Kane, John L Black, et al.
Methods in Molecular Medicine|April 25, 2003
Gene expression microarraysChristopher P Kolbert, William R Taylor, Kelly L Krajnik, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2003
Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladderJalaluddin Bhuiyan, Javed Akhter, Dennis J O'Kane
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2007
The impact of CYP allelic variation on antidepressant metabolism: a reviewJohn L Black, Dennis J O'Kane, David A Mrazek
Pharmacogenomics|January 9, 2003
Pharmacogenomics and reducing the frequency of adverse drug eventsDennis J O'Kane, Richard M Weinshilboum, Thomas P Moyer
Clinical Chemistry|January 17, 2004
Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytomaSusan A Lagerstedt, Dennis J O'Kane, Ravinder J Singh
Clinical Biochemistry|July 7, 2009
Use of cyst fluid CEA, CA19-9, and amylase for evaluation of pancreatic lesionsChristine L H Snozek, Ranjan C Mascarenhas, Dennis J O'Kane
The Journal of Molecular Diagnostics : JMD|August 1, 2009
Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathologyChristine L H Snozek, Dennis J O'Kane, Alicia Algeciras-Schimnich
Clinics in Laboratory Medicine|December 9, 2008
Pharmacogenomics of tamoxifen and irinotecan therapiesAlicia Algeciras-Schimnich, Dennis J O'Kane, Christine L H Snozek
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2011
Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype predictionJohn Logan Black, Denise L Walker, Dennis J O'Kane, et al.
Mayo Clinic Proceedings|September 7, 2007
Cytochrome P450 2D6 genotype variation and venlafaxine dosageDonald E McAlpine, Dennis J O'Kane, John L Black, et al.
Methods in Molecular Medicine|April 25, 2003
Gene expression microarraysChristopher P Kolbert, William R Taylor, Kelly L Krajnik, et al.
Pageof 3